BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 21
• 22
• 23
• 24
• 25
• 26
• 28
• 29
• 30

• Press Releases

  Eupraxia Pharmaceuticals Announces Pricing of US$70 Million Public Offering of Common Shares

  September 23, 2025

   · 

  8 min read
• Press Releases

  GC Biopharma Submits IND Application for Phase 1 Clinical Trial of COVID-19 mRNA Vaccine in Korea

  September 23, 2025

   · 

  3 min read
• Press Releases

  MindMed Announces New Employee Inducement Grants - September 22, 2025

  September 23, 2025

   · 

  1 min read
• Press Releases

  Corcept to Present New Late-Breaking Data From Pivotal ROSELLA Trial of Relacorilant in Platinum-Resistant Ovarian Cancer at ESMO 2025

  September 23, 2025

   · 

  4 min read
• Press Releases

  Lexicon Pharmaceuticals Announces Update on Submission of Additional Data to U.S. FDA Supporting the Benefit-Risk Profile of Zynquista® in Type 1 Diabetes

  September 23, 2025

   · 

  4 min read
• Press Releases

  CatalYm to Present Primary Results From Phase 2 Neoadjuvant Bladder Cancer Trial in Late-breaking Oral Presentation at ESMO

  September 23, 2025

   · 

  3 min read
• Press Releases

  Eupraxia Pharmaceuticals Announces Proposed Public Offering of Common Shares

  September 23, 2025

   · 

  7 min read
• Press Releases

  MaxCyte Announces Operational Restructuring to Reduce Costs and Accelerate Path to Profitability

  September 23, 2025

   · 

  4 min read
• Press Releases

  Until Labs Announces $58M Series A Funding Round, to Develop an Organ Cryopreservation Product for Transplant Patients and Surgeons

  September 23, 2025

   · 

  1 min read
• Press Releases

  GENFIT Reports First-Half 2025 Financial Results and Provides Corporate Update

  September 23, 2025

   · 

  34 min read